Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- NCT ID
- NCT07717879
- Registry status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Sponsor
- Axsome Therapeutics, Inc.
- Conditions
- ADHD
Overview
ClinicalTrials.gov lists this study as Recruiting.
Official title: A Phase 3, Randomized, 6-Week, Double-blind, Placebo-controlled Trial of Solriamfetol in Children Aged 6 to <12 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Enrollment: 468 participants (Estimated).
What is being studied
- Drug: Placebo
- Drug: Solriamfetol Dose A
- Drug: Solriamfetol Dose B
Who may be eligible
- Ages
- 6 Years to 11 Years
- Sex
- All
- Healthy volunteers accepted
- No
ClinicalTrials.gov lists the following eligibility criteria.
Study locations
23 study locations are listed.
Recruiting site status is explicitly provided for 23 locations; 23 are listed as Recruiting.
Countries: United States
- Alabama, United States: 1
- Arkansas, United States: 1
- California, United States: 4
- Florida, United States: 4
- Georgia, United States: 1
- Kentucky, United States: 1
- Massachusetts, United States: 2
- Mississippi, United States: 1
- Nevada, United States: 1
- New York, United States: 1
- South Carolina, United States: 1
- Tennessee, United States: 1
- Texas, United States: 3
- Utah, United States: 1
Sample of listed locations
- Clinical Research Site — Dothan, Alabama, 36303, United States — Recruiting
- Clinical Research Site — Little Rock, Arkansas, 72211, United States — Recruiting
- Clinical Research Site — Irvine, California, 92604, United States — Recruiting
- Clinical Research Site — Long Beach, California, 90806, United States — Recruiting
- Clinical Research Site — Orange, California, 92868, United States — Recruiting
- Clinical Research Site — Walnut Creek, California, 94596, United States — Recruiting
- Clinical Research Site — Coral Gables, Florida, 33146, United States — Recruiting
- Clinical Research Site — Jacksonville, Florida, 32256, United States — Recruiting
- Clinical Research Site — Maitland, Florida, 32751, United States — Recruiting
- Clinical Research Site — Orlando, Florida, 32801, United States — Recruiting
- Clinical Research Site — Atlanta, Georgia, 30318, United States — Recruiting
- Clinical Research Site — Bardstown, Kentucky, 40004, United States — Recruiting
- Clinical Research Site — Springfield, Massachusetts, 01103, United States — Recruiting
- Clinical Research Site — Worcester, Massachusetts, 01608, United States — Recruiting
- Clinical Research Site — Jackson, Mississippi, 39206, United States — Recruiting
- Clinical Research Site — Las Vegas, Nevada, 89128, United States — Recruiting
- Clinical Research Site — Staten Island, New York, 10314, United States — Recruiting
- Clinical Research Site — North Charleston, South Carolina, 29405, United States — Recruiting
- Clinical Research Site — Memphis, Tennessee, 38119, United States — Recruiting
- Clinical Research Site — Austin, Texas, 78759, United States — Recruiting
- Clinical Research Site — Friendswood, Texas, 77546, United States — Recruiting
- Clinical Research Site — San Antonio, Texas, 78229, United States — Recruiting
- Clinical Research Site — Provo, Utah, 84604, United States — Recruiting
Study details
- Start date
- July 6, 2026
- Primary completion date
- June 30, 2028
- Completion date
- June 30, 2028
- First posted
- July 21, 2026
Source and update information
- Source
- ClinicalTrials.gov
- NCT ID
- NCT07717879
- Registry last updated
- September 8, 2026
- QualifiedStudies registry data refreshed
- September 28, 2026
- QualifiedStudies record fetched
- September 28, 2026
View NCT07717879 on ClinicalTrials.gov
Trial information can change. Confirm current study details with the study team or the registry.
About joining clinical research
Find clinical trials you may match with
QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.
Find clinical trials you may match with | ADHD studies | Clinical trial FAQ